Connect with us

National

Has Australia done enough to secure vaccines? – The Australian Financial Review

The COVID-19 outbreak on Sydney’s northern beaches this week has again put the nation on edge. it’s a brutal reminder that Australia’s health crisis is far from…

Published

on

Of the 140 million doses acquired by Australia, more than 100 million come from just two suppliers: the UK pharmaceutical giant AstraZeneca and US company Novavax; a further 10 million come from US multinational Pfizer.
All three vaccine candidates are still to receive full non-emergency regulatory approval in Australia and overseas, though they represent the most advanced and successful options on the market.
The remaining 25 million doses are part of the global COVAX facility, the future of which…

Click here to view the original article.